John Park

Medical Oncologist, Macquarie University Clinical Associates (MUCA)
Senior Lecturer, Department of Clinical Medicine
Faculty of Medicine, Health and Human Sciences

Emailjohn.park@mqhealth.org.au, john.park4@hdr.mq.edu.au

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where John Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
2 Finished
8 Active

EFC15935: A randomized, multicentre, double-blind phase 3 study of SAR439859 plus palbociclib versus letrozole plus palbociclib for the treatment of patients with ER (+), HER2 (-) breast cancer who have not received prior systemic anti-cancer treatment for advanced disease
Sabanathan, D., Park, J. & Chapman, N.
30/09/20 → 30/09/25
Project: Research
SHR-A1811-1-101: A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects
Park, J. & Chapman, N.
28/09/20 → 31/12/22
Project: Research
YH002002: A First-in-Human, Multicenter, Open-Label, Phase 1 Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of YH002 in Subjects with Advanced Solid Malignancies
Park, J. & Chapman, N.
18/09/20 → 30/07/25
Project: Research
ADG116-1003: A Phase 1, Open-Label, Dose Escalation Study of ADG116 in Patients with Advanced/Metastatic Solid Tumors
Park, J., Chapman, N. & Sabanathan, D.
14/09/20 → 27/08/25
Project: Research
ACT16146: Randomized, open-label, phase 2 study of SAR408701 combined with pembrolizumab and pembrolizumab alone in patients with CEACAM5 and PD-L1 positive advanced/metastatic non-squamous non–small-cell lung cancer (NSQ NSCLC)
Park, J. & Chapman, N.
14/08/20 → 1/07/25
Project: Research

856 Citations
9 h-Index
15 Article
1 Letter
1 Review article

The impact of nonsteroidal anti-inflammatory drugs, beta blockers, and metformin on the efficacy of anti-PD-1 therapy in advanced melanoma
Wang, D. Y., McQuade, J. L., Rai, R. R., Park, J. J., Zhao, S., Ye, F., Beckermann, K. E., Rubinstein, S. M., Johnpulle, R., Long, G. V., Carlino, M. S., Menzies, A. M., Davies, M. A. & Johnson, D. B., 1 Mar 2020, In : Oncologist. 25, 3, p. e602-e605 4 p.
Research output: Contribution to journal › Article
5 Citations (Scopus)
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Johansson, P. A., Brooks, K., Newell, F., Palmer, J. M., Wilmott, J. S., Pritchard, A. L., Broit, N., Wood, S., Carlino, M. S., Leonard, C., Koufariotis, L. T., Nathan, V., Beasley, A. B., Howlie, M., Dawson, R., Rizos, H., Schmidt, C. W., Long, G. V., Hamilton, H., Kiilgaard, J. F. & 15 others, Isaacs, T., Gray, E. S., Rolfe, O. J., Park, J. J., Stark, A., Mann, G. J., Scolyer, R. A., Pearson, J. V., van Baren, N., Waddell, N., Wadt, K. W., McGrath, L. A., Warrier, S. K., Glasson, W. & Hayward, N. K., 15 May 2020, In : Nature Communications. 11, 1, p. 1-8 8 p., 2408.
Research output: Contribution to journal › Article

Open Access
File
5 Citations (Scopus)

2 Downloads (Pure)
Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma
Hwang, S. J. E., Park, J. J. W., Wakade, D., Chou, S., Byth, K. & Fernández-Peñas, P., Apr 2019, In : Melanoma Research. 29, 2, p. 172-177 6 p.
Research output: Contribution to journal › Article
5 Citations (Scopus)
Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma
da Silva, I. P., Wang, K. Y. X., Wilmott, J. S., Holst, J., Carlino, M. S., Park, J. J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Johnson, D. B., McQuade, J. L., Rai, R., Kefford, R. F., Rizos, H., Scolyer, R. A., Yang, J. Y. H., Long, G. V. & Menzies, A. M., 15 Feb 2019, In : Clinical Cancer Research. 25, 4, p. 1272-1279 8 p.
Research output: Contribution to journal › Article
16 Citations (Scopus)
Paradigm shift in local consolidative therapy for oligometastatic non-small cell lung cancer: a meta-analysis
Cao, C., Chakos, A., Guo, A., Park, J. J., Saghaie, T. & Blinman, P., Dec 2019, In : Annals of Translational Medicine. 7, Suppl 8, p. 1-4 4 p., S320.
Research output: Contribution to journal › Article

Open Access
File

9 Downloads (Pure)